Related Experiment Videos
Genetics, genomics and proteomics in atherosclerosis research
Tiina T Tuomisto1, Bernd R Binder, Seppo Ylä-Herttuala
1Department of Biotechnology and Molecular Medicine, A. I. Virtanen Institute, Kuopio University, Kuopio, Finland.
Annals of Medicine
|September 24, 2005
Summary
Atherosclerosis, a major cause of death, involves complex genetic and environmental factors. Understanding atherogenetics, atherogenomics, and atheroproteomics is crucial for developing new therapies, with microarray technology playing a key role.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Genomics
Background:
- Atherosclerosis is a leading cause of mortality in Western nations.
- It is a complex, multifactorial disease involving endothelial dysfunction, smooth muscle cell proliferation, inflammation, lipid accumulation, and thrombus formation.
- Genetic and environmental factors interact to influence atherogenesis.
Purpose of the Study:
- To review current knowledge on genetic factors (atherogenetics), gene expression (atherogenomics), and protein expression (atheroproteomics) in atherosclerosis.
- To highlight the role of microarray technology in advancing atherosclerosis research.
- To provide insights into fundamental pathobiological mechanisms for developing targeted therapies.
Main Methods:
- Literature review focusing on atherogenetics, atherogenomics, and atheroproteomics.
- Emphasis on the application and findings derived from microarray technology in atherosclerosis studies.
- Synthesis of current understanding of molecular mechanisms in atherogenesis.
Main Results:
- Atherosclerosis pathogenesis is influenced by a combination of genetic predispositions and environmental triggers.
- Gene expression profiling via microarrays has identified key molecular pathways implicated in the disease.
- Proteomic studies are revealing critical protein alterations contributing to atherosclerotic development.
Conclusions:
- Comprehensive understanding of atherogenetics, atherogenomics, and atheroproteomics is essential for effective therapeutic strategies.
- Microarray technology has significantly advanced the study of gene expression patterns in atherosclerosis.
- Further research integrating genetic, gene expression, and protein data is needed to combat atherosclerosis effectively.